Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice
about
Alcoholic liver disease and hepatitis C: a frequently underestimated combinationMicronutrient Antioxidants and Nonalcoholic Fatty Liver DiseaseAberrant post-translational protein modifications in the pathogenesis of alcohol-induced liver injuryAlcoholic Liver Disease: Update on the Role of Dietary FatEffect of alcohol on adipose tissue: a review on ethanol mediated adipose tissue injuryInsulin resistance in clinical and experimental alcoholic liver diseaseAlcoholic liver disease: the gut microbiome and liver cross talkAlcoholic liver disease: pathogenesis and new therapeutic targets.Pyruvate dehydrogenase kinase isoenzyme 4 (PDHK4) deficiency attenuates the long-term negative effects of a high-saturated fat dietChronic ethanol feeding to rats decreases adiponectin secretion by subcutaneous adipocytesToll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis.Animals models of gastrointestinal and liver diseases. Animal models of alcohol-induced liver disease: pathophysiology, translational relevance, and challengesRelationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease.Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice.Inflammatory mediators of hepatic steatosis.New therapeutic targets in alcoholic hepatitis.Animal Models of Alcoholic Liver Disease: Pathogenesis and Clinical RelevanceEpigenetic regulation of hepatic endoplasmic reticulum stress pathways in the ethanol-fed cystathionine beta synthase-deficient mouse.Wild bitter gourd protects against alcoholic fatty liver in mice by attenuating oxidative stress and inflammatory responses.Identification of 5' AMP-activated kinase as a target of reactive aldehydes during chronic ingestion of high concentrations of ethanol.CCl4-induced hepatic injury in mice fed a Western diet is associated with blunted healing.Role of pyruvate dehydrogenase kinase 4 in regulation of blood glucose levels.Exploring the molecular mechanisms underlying the potentiation of exogenous growth hormone on alcohol-induced fatty liver diseases in mice.Treatment of alcoholic liver disease.Chronic alcohol exposure disturbs lipid homeostasis at the adipose tissue-liver axis in mice: analysis of triacylglycerols using high-resolution mass spectrometry in combination with in vivo metabolite deuterium labelingChronic free-choice drinking in crossed high alcohol preferring mice leads to sustained blood ethanol levels and metabolic tolerance without evidence of liver damage.Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in miceAdipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.Template to improve glycemic control without reducing adiposity or dietary fat.Role of SIRT1-FoxO1 signaling in dietary saturated fat-dependent upregulation of liver adiponectin receptor 2 in ethanol-administered miceA model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury.Antilipogenic and anti-inflammatory activities of Codonopsis lanceolata in mice hepatic tissues after chronic ethanol feedingSirtuin 1 signaling and alcoholic fatty liver disease.Ethanol-induced oxidative stress via the CYP2E1 pathway disrupts adiponectin secretion from adipocytesRegulation of glucose and lipid homeostasis by adiponectin: effects on hepatocytes, pancreatic β cells and adipocytesHerbal SGR Formula Prevents Acute Ethanol-Induced Liver Steatosis via Inhibition of Lipogenesis and Enhancement Fatty Acid Oxidation in MiceDifferential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice.Behavioral, Metabolic, and Immune Consequences of Chronic Alcohol or Cannabinoids on HIV/AIDs: Studies in the Non-Human Primate SIV ModelMultiparity leads to obesity and inflammation in mothers and obesity in male offspring.Activation of peroxisome proliferator-activated receptor-γ by rosiglitazone improves lipid homeostasis at the adipose tissue-liver axis in ethanol-fed mice.
P2860
Q22305502-5680EF13-C0EE-4533-855A-E9B626C79223Q26738646-D84D2E6D-B417-457D-AEBD-B9038D89C903Q26741179-49DFAA89-295C-4EFA-8717-40245D793DC3Q26769970-D92CCBA5-DF01-440B-BB1B-5025BF7566E4Q26785565-DC360595-6F29-4455-AB9B-42026E9520B1Q26865988-9909466D-BC48-49B2-93A6-632ADFA39039Q27025627-3DD25278-D938-4ADE-9255-3B85CF0FD8B0Q27690220-E9050BA9-B7CE-4433-B274-0DE608191E43Q28510446-AAE2AB3E-2305-43F7-8B46-D2105F1D866BQ28574215-97029417-55B6-49E5-9DA5-3225BB84287BQ30983737-C1C37ECB-DB4B-421C-A278-77825CDC967FQ33626594-839FE223-B8C5-4C4A-8C89-821223294D8AQ33719929-1F78C147-0A0B-4A80-B72E-1DBB5AD4A6EDQ33727352-7946CA9F-3A2E-40BE-8DDB-CBB5C302F86BQ33734136-27CBE62D-AB2E-453D-9EA5-50764746D467Q33757267-F0F541C2-2832-4D09-A0CB-6C64F5CD8A03Q33882332-78E620EA-72FB-4D97-9217-3878D959BBEBQ33966384-BE4C97EE-B97E-4A63-B2DF-5BC1FF739D8DQ34040303-D1958F4B-20CE-435D-9CE9-0CC75DDF0746Q34075939-7AF5429D-7892-4B49-8DA1-8F63B4B56E3FQ34192801-B6BEE58B-A86C-4A88-969C-279DA5D88B41Q34274653-45E8DAE4-7070-4814-8471-31C93CD96478Q34366594-32987B9B-F469-40A9-B23C-CE9BC2FA99C6Q34565692-802A3537-4AEB-444F-A2D7-79CAAE6A940EQ34584201-29DAD922-78A1-484E-BB51-BE45E024FA3CQ34653245-28547EB2-7C52-4660-93F1-0D5FE99141F4Q34759068-20BDD3A2-9EAB-4894-942B-3E43E4F4C790Q34779049-78C0538D-55D1-4404-ADBE-99815831BD9DQ34979386-F8B71573-2EA4-46C7-9B4E-527FAC09BFA8Q35055513-7C6CFF3F-A508-4E42-BFA9-D40B55915875Q35222087-572FBD26-3BEE-474B-84BB-00F1A04E25B1Q35370819-30729A84-32CD-4E27-8F66-E2EC581FF962Q35513589-F48881F0-0360-4FC7-AC47-79E300D93E65Q35605812-62D80B90-8A30-4CFA-9035-7975EAA30DF1Q35683960-2E03AFBC-1AE8-48D9-930A-36D3B948102FQ35691565-FEB6272A-58A7-454B-BAD3-8F3ADEA0F180Q35721145-CE4036DA-208C-4A84-94A2-C4E23BDC25DEQ35751830-8985F2C9-F4FA-439F-94C9-3631F7209F1BQ35780719-5E685CB6-7C9F-446A-8C84-95DEF1D748C4Q35849950-C512508D-B1B2-4D8C-B55F-967851C539EB
P2860
Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Role of adiponectin in the pro ...... alcoholic fatty liver in mice
@ast
Role of adiponectin in the pro ...... alcoholic fatty liver in mice
@en
Role of adiponectin in the pro ...... alcoholic fatty liver in mice
@nl
type
label
Role of adiponectin in the pro ...... alcoholic fatty liver in mice
@ast
Role of adiponectin in the pro ...... alcoholic fatty liver in mice
@en
Role of adiponectin in the pro ...... alcoholic fatty liver in mice
@nl
prefLabel
Role of adiponectin in the pro ...... alcoholic fatty liver in mice
@ast
Role of adiponectin in the pro ...... alcoholic fatty liver in mice
@en
Role of adiponectin in the pro ...... alcoholic fatty liver in mice
@nl
P2093
P2860
P356
P1433
P1476
Role of adiponectin in the pro ...... alcoholic fatty liver in mice
@en
P2093
Daniel P Kelly
David W Crabb
Robert V Considine
Teresa C Leone
P2860
P304
P356
10.1002/HEP.20821
P407
P577
2005-09-01T00:00:00Z